Acadia Pharmaceuticals Inc. (ACAD)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
30-Apr-21 6:55 PM
View: 
Ridloff Elena
EVP and CFO
Acadia Pharmaceuticals Inc. (ACAD) 30-Apr-21Market Option Sale 1,032$20.33$20,980.60(9%)
11.59K to 10.55K
30-Apr-21 6:54 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 30-Apr-21Market Option Sale 1,054$20.33$21,427.80(8%)
12.43K to 11.37K
30-Apr-21 6:53 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 30-Apr-21Market Option Sale 4,230$20.33$85,995.90(10%)
40.66K to 36.43K
30-Apr-21 6:52 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 30-Apr-21Market Option Sale 7,850$20.33$159,590.00(14%)
57.16K to 49.31K
30-Apr-21 6:52 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 29-Apr-21Option Exercise 15,625----38%
41.54K to 57.16K
30-Apr-21 6:55 PM
View: 
Ridloff Elena
EVP and CFO
Acadia Pharmaceuticals Inc. (ACAD) 29-Apr-21Option Exercise 3,245----39%
8.34K to 11.59K
30-Apr-21 6:54 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 29-Apr-21Option Exercise 3,005----32%
9.42K to 12.43K
30-Apr-21 6:53 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 29-Apr-21Option Exercise 9,615----31%
31.05K to 40.66K
08-Feb-21 9:00 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Grant 31,250----264%
11.85K to 43.09K
08-Feb-21 9:00 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Market Sale 14,195$50.61$718,409.00(33%)
43.09K to 28.9K
08-Feb-21 9:00 PM
View: 
Ridloff Elena
EVP and CFO
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Grant 6,490----166%
3.9K to 10.39K
08-Feb-21 9:00 PM
View: 
Ridloff Elena
EVP and CFO
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Market Sale 2,051$50.61$103,801.00(20%)
10.39K to 8.34K
08-Feb-21 9:00 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Grant 6,009----100%
6.01K to 12.02K
08-Feb-21 9:00 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Grant 19,231----95%
20.25K to 39.48K
08-Feb-21 9:00 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Market Sale 2,107$50.61$106,635.00(18%)
12.02K to 9.91K
08-Feb-21 9:00 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 04-Feb-21Market Sale 8,429$50.61$426,592.00(21%)
39.48K to 31.05K
14-Jan-21 7:03 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 12-Jan-21Market Option Sale (Planned) 700$55.01$38,507.00(3%)
20.95K to 20.25K
14-Jan-21 7:03 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 12-Jan-21Option Exercise 700$18.12$12,684.003%
20.25K to 20.95K
08-Jan-21 7:28 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 08-Jan-21Option Exercise 29,733$27.44$815,988.00147%
20.25K to 49.98K
08-Jan-21 7:28 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 08-Jan-21Market Option Sale (Planned) 29,733$55.22$1,641,830.00(59%)
49.98K to 20.25K
08-Jan-21 7:28 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 07-Jan-21Option Exercise 61,619$35.80$2,205,960.00304%
20.25K to 81.87K
08-Jan-21 7:28 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 07-Jan-21Market Option Sale (Planned) 61,619$55.12$3,396,190.00(75%)
81.87K to 20.25K
08-Jan-21 7:29 PM
View: 
Ridloff Elena
EVP and CFO
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Market Option Sale 1,016$53.34$54,193.40(21%)
4.92K to 3.9K
08-Jan-21 7:30 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Market Option Sale 678$53.34$36,164.50(11%)
6.2K to 5.52K
08-Jan-21 7:31 PM
View: 
Yang Michael J.
EVP AND CCO
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Option Exercise 2,722----42%
6.46K to 9.18K
08-Jan-21 7:28 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Market Option Sale 1,725$53.34$92,011.50(8%)
21.97K to 20.25K
08-Jan-21 7:28 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Option Exercise 9,527----52%
18.44K to 27.97K
08-Jan-21 7:31 PM
View: 
Yang Michael J.
EVP AND CCO
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Market Option Sale 1,120$53.34$59,740.80(12%)
9.18K to 8.06K
08-Jan-21 7:29 PM
View: 
Ridloff Elena
EVP and CFO
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Option Exercise 2,722----124%
2.19K to 4.92K
08-Jan-21 7:28 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Market Option Sale 3,484$53.34$185,837.00(12%)
27.97K to 24.48K
08-Jan-21 7:30 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Option Exercise 1,633----36%
4.56K to 6.2K
08-Jan-21 7:28 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 06-Jan-21Option Exercise 5,444----33%
16.53K to 21.97K
20-Nov-20 9:29 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 20-Nov-20Market Option Sale 2,728$53.50$145,948.00(14%)
19.26K to 16.53K
20-Nov-20 9:29 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 19-Nov-20Option Exercise 6,250----48%
13.01K to 19.26K
29-Oct-20 4:12 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 27-Oct-20Market Option Sale (Planned) 8,750$45.10$394,636.00(69%)
12.6K to 3.85K
29-Oct-20 4:12 PM
View: 
Kim Austin D.
EVP & General Counsel
Acadia Pharmaceuticals Inc. (ACAD) 27-Oct-20Option Exercise 8,750$17.58$153,825.00227%
3.85K to 12.6K
19-Oct-20 5:25 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 16-Oct-20Market Option Sale 2,960$42.56$125,978.00(17%)
17.75K to 14.79K
19-Oct-20 5:26 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 16-Oct-20Market Option Sale 1,297$42.56$55,200.30(9%)
14.3K to 13.01K
19-Oct-20 5:27 PM
View: 
Yang Michael J.
EVP AND CCO
Acadia Pharmaceuticals Inc. (ACAD) 16-Oct-20Market Option Sale 1,247$42.56$53,072.30(16%)
7.7K to 6.46K
19-Oct-20 5:27 PM
View: 
Yang Michael J.
EVP AND CCO
Acadia Pharmaceuticals Inc. (ACAD) 15-Oct-20Option Exercise 2,500----48%
5.2K to 7.7K
19-Oct-20 5:25 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 15-Oct-20Option Exercise 5,937----50%
11.81K to 17.75K
19-Oct-20 5:26 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 15-Oct-20Option Exercise 2,969----26%
11.33K to 14.3K
09-Jul-20 6:26 PM
View: 
Yang Michael J.
EVP AND CCO
Acadia Pharmaceuticals Inc. (ACAD) 07-Jul-20Market Option Sale (Planned) 27,250$56.25$1,532,790.00(84%)
32.45K to 5.2K
09-Jul-20 6:26 PM
View: 
Yang Michael J.
EVP AND CCO
Acadia Pharmaceuticals Inc. (ACAD) 07-Jul-20Option Exercise 27,250$23.00$626,770.00524%
5.2K to 32.45K
25-Jun-20 6:18 PM
View: 
Baker Bros Advisors LLC
Director
10% Owner
Acadia Pharmaceuticals Inc. (ACAD) 23-Jun-20Grant 12,236----< 1%
42.01M to 42.02M
19-Jun-20 6:55 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 19-Jun-20Option Exercise 16,452$18.12$298,110.00145%
11.33K to 27.79K
19-Jun-20 6:55 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 19-Jun-20Market Option Sale (Planned) 16,452$50.12$824,515.00(59%)
27.79K to 11.33K
19-Jun-20 6:55 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 18-Jun-20Market Option Sale (Planned) 65,843$50.01$3,292,730.00(85%)
77.18K to 11.33K
19-Jun-20 6:55 PM
View: 
Stankovic Srdjan R.
President
Acadia Pharmaceuticals Inc. (ACAD) 18-Jun-20Option Exercise 65,843$18.81$1,238,700.00581%
11.33K to 77.18K
15-May-20 7:11 PM
View: 
Davis Stephen
CEO
Director
Acadia Pharmaceuticals Inc. (ACAD) 14-May-20Market Option Sale (Planned) 88,542$45.62$4,039,100.00(88%)
100.35K to 11.81K